Product image of Levetiracetam Ametas (Levetiracetam) supplied by GNH India

Levetiracetam Ametas

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam Ametas (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam Ametas, is an anticonvulsant presented as an oral tablet for oral use. It is employed to control various seizure types in patients with epilepsy, including partial, generalized tonic‑clonic, and myoclonic seizures, offering a broad spectrum of seizure management and is well‑tolerated in clinical practice.

GNH India supplies Levetiracetam Ametas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Manufacturer / TM Owner

Ametas Medical Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levetiracetam is an antiepileptic drug that acts on seizure activity across several epilepsy syndromes.

  • Partial seizures: reduces seizure frequency and severity in patients with focal onset seizures.
  • Generalized tonic-clonic seizures: helps control convulsive episodes in individuals with generalized epilepsy.
  • Myoclonic seizures: diminishes rapid muscle jerks associated with myoclonic epilepsy.

How It Works

  • Levetiracetam binds to the synaptic vesicle protein SV2A, modulating neurotransmitter release and stabilizing neuronal membranes. This interaction reduces abnormal neuronal excitability and synchronised firing that underlie seizure generation. By influencing calcium‑dependent vesicle exocytosis, the drug attenuates the propagation of epileptiform activity without directly affecting ion channels or G‑protein pathways. The precise downstream effects remain under investigation, but the overall result is a decrease in seizure susceptibility.

Side Effects

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Dizziness: sensation of light‑headedness or imbalance.
  • Fatigue: feeling unusually tired or weak.
  • Headache: mild to moderate cranial pain.
  • Irritability or mood changes: increased agitation or emotional lability.

Serious or Rare Side Effects

  • Severe allergic reaction: rash, swelling, or anaphylaxis.
  • Mood or behavioral disturbances: depression, suicidal thoughts, or aggression.
  • Hematologic abnormalities: low blood cell counts such as neutropenia or thrombocytopenia.

Precautions & Warnings

When prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure safe use.

  • Renal function: adjust dose in patients with impaired renal clearance.
  • Psychiatric history: monitor for mood changes or suicidal ideation.
  • Concomitant CNS depressants: use caution as additive sedation may occur.
  • Pregnancy and lactation: evaluate risks versus benefits before use.
  • Drug discontinuation: taper gradually to avoid seizure exacerbation.
  • Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

Avoid Interactions

Levetiracetam can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid)

  • Carbamazepine: may reduce levetiracetam plasma levels, decreasing effectiveness.
  • Enzyme‑inducing antiepileptics (e.g., phenobarbital, phenytoin): can lower levetiracetam concentrations.

Moderate Interactions (Monitor Closely)

  • Sedative agents (e.g., benzodiazepines, alcohol): may increase central nervous system depression.
  • Antidepressants (e.g., SSRIs): monitor for enhanced mood changes.
  • Oral contraceptives: levetiracetam may slightly reduce hormonal efficacy; advise additional contraceptive measures.

Frequently Asked Questions

Levetiracetam Ametas is used to treat epilepsy by reducing the frequency of partial, generalized tonic‑clonic, and myoclonic seizures. It is prescribed for patients who require control of seizure activity across these major seizure types.

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This action stabilises neuronal membranes and lowers abnormal neuronal excitability, thereby decreasing the likelihood of seizure generation.

The dosage of Levetiracetam Ametas is determined by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. The prescriber will set an individualized regimen that may be adjusted over time.

Data on levetiracetam use in pregnancy and lactation are limited. Clinicians weigh potential benefits against possible risks, and the decision is made on a case‑by‑case basis. Women who are pregnant or nursing should discuss treatment options with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam offers a favourable safety profile and minimal drug‑enzyme interactions compared with many older antiepileptics such as carbamazepine or valproate. It is often chosen when rapid titration is needed or when patients have experienced adverse effects with other agents.

Levetiracetam Ametas should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date.

The medication is taken orally, usually with water. It can be swallowed with or without food, according to the prescriber’s instructions. Patients should follow the dosing schedule provided by their healthcare professional.

Serious risks include severe allergic reactions (such as rash or anaphylaxis), mood or behavioral disturbances (including depression, suicidal thoughts, or aggression), and rare hematologic abnormalities like neutropenia or thrombocytopenia. Prompt medical attention is required if any of these occur.

Individuals with a known hypersensitivity to levetiracetam or any of its excipients should avoid the product. Patients with severe renal impairment must have dose adjustments and close monitoring; otherwise, use is contraindicated.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT